{
  "docId": "019de516-01ce-701d-bd9b-acac15fa9fab",
  "docSlug": "a13be9775a99db49a0c5c2ac3ee2ea88",
  "documentTitle": "Oculis | Investor Conference Presentation Deck | 39 slides",
  "authorId": "oculis",
  "authorName": "Oculis",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 34,
  "pageCount": 39,
  "prevPage": 33,
  "nextPage": 35,
  "slideType": "propose_solution",
  "function": "propose_solution",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de516-01ce-701d-bd9b-acac15fa9fab/34",
  "deckHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab",
  "deckJsonHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab.json",
  "deckAnchorHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab#slide-34",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.11,
        "x": 0.85,
        "y": 0.04
      },
      "kind": "image",
      "text": "Oculis",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c39a2ee-78d5-453c-8472-ca3abedf7333",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.02,
        "x": 0.95,
        "y": 0.94
      },
      "kind": "legend",
      "text": "34",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6a17abe1-c2f0-4960-9200-3dfd0ea20210",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.84,
        "x": 0.05,
        "y": 0.205
      },
      "kind": "list",
      "text": "First SGK Neuroprotective Ophthalmic Candidate: Disease modifying drug which protects and repairs neurons",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "119411b2-3ddc-407c-b758-4190984e5cea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.84,
        "x": 0.05,
        "y": 0.72
      },
      "kind": "list",
      "text": "Upcoming Value Inflection: Proof-of-concept data readout in AON expected in 2024",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4be96f7a-d5a0-4c09-82c6-fce32fa6770d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.84,
        "x": 0.05,
        "y": 0.535
      },
      "kind": "list",
      "text": "Data Supporting MoA and Safety: Preclinical data showing neuroprotection by preventing retinal ganglion cell death and improvement of function in Glaucoma, MS(1) and AON models; Phase 1 study data demonstrated OCS-05 was well-tolerated in 48 healthy volunteers",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8d191e66-1848-477c-b119-0c21f316a920",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.84,
        "x": 0.05,
        "y": 0.37
      },
      "kind": "list",
      "text": "High Potential Commercial Impact: Potential application in ophthalmology including Glaucoma, Geographic Atrophy, Diabetic Retinopathy, and corneal indications such as Neurotrophic Keratitis",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a2be861-3f4a-4a42-a55d-394c9cad24ca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.09,
        "x": 0.026,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "(1) Multiple Sclerosis.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bfe7d5c1-8411-4b21-a014-6dd76641d24d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.82,
        "x": 0.026,
        "y": 0.04
      },
      "kind": "title",
      "text": "OCS-05 First SGK Neuroprotective Candidate in Ophthalmology",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fa2f4c82-1596-4171-8796-ea147d4f5dca",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "c549ec3a-c057-4073-86ec-758a8c65fd5d",
      "evidence": "list/bullet: Data Supporting MoA and Safety: Preclinical data showing neuroprotection by preventing retinal ganglion cell death and improvement of function in Glaucoma, MS(1) and AON models; Phase 1 study data demonstrat",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 39,
      "from": 25,
      "beatId": "6cce666b-f795-4a3e-a589-afe2a7266ece",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Slides 25-39 discuss OCS-02, OCS-05, and the track record of efficient capital deployment.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}